These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8373918

  • 41. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
    Willoughby JO, Menadue M, Jervois P.
    Brain Res; 1982 Oct 14; 249(2):291-9. PubMed ID: 6291713
    [Abstract] [Full Text] [Related]

  • 42. Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
    Van de Kar LD, Urban JH, Richardson KD, Bethea CL.
    Neuroendocrinology; 1985 Oct 14; 41(4):283-8. PubMed ID: 2931613
    [Abstract] [Full Text] [Related]

  • 43. Central serotoninergic stimulation by fenfluramine challenge does not affect plasma thyrotropin-stimulating hormone levels in man.
    Coccaro EF, Siever LJ, Kourides IA, Adan F, Campbell G, Davis KL.
    Neuroendocrinology; 1988 Apr 14; 47(4):273-6. PubMed ID: 3374753
    [Abstract] [Full Text] [Related]

  • 44. Role of gonadal steroids in the serotoninergic control of prolactin secretion in men.
    Foresta C, Indino M, Scandellari C.
    Clin Endocrinol (Oxf); 1987 May 14; 26(5):601-7. PubMed ID: 3665121
    [Abstract] [Full Text] [Related]

  • 45. The influence of fenfluramine stimulation on prolactin plasma levels in lithium long-term-treated manic-depressive patients and healthy subjects.
    Mühlbauer HD.
    Pharmacopsychiatry; 1984 Nov 14; 17(6):191-3. PubMed ID: 6514782
    [Abstract] [Full Text] [Related]

  • 46. Repeated cocaine exposure inhibits the adrenocorticotropic hormone response to the serotonin releaser d-fenfluramine and the 5-HT1A agonist, 8-OH-DPAT.
    Levy AD, Li Q, Van de Kar LD.
    Neuropharmacology; 1994 Nov 14; 33(3-4):335-42. PubMed ID: 7984271
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J, Toll C, Schonlau P, Rohrmann S, Netter P.
    Neuropsychobiology; 2000 Nov 14; 41(1):38-47. PubMed ID: 10629434
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Prolactin response to D-fenfluramine in outpatients with major depression.
    Kavoussi RJ, Kramer J, Hauger RL, Coccaro EF.
    Psychiatry Res; 1998 Jul 13; 79(3):199-205. PubMed ID: 9704866
    [Abstract] [Full Text] [Related]

  • 51. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Casanueva FF, Villanueva L, Peñalva A, Cabezas-Cerrato J.
    Neuroendocrinology; 1984 Apr 13; 38(4):302-8. PubMed ID: 6374488
    [Abstract] [Full Text] [Related]

  • 52. Endocrine and amine responses to D,L-fenfluramine in normal subjects.
    Mitchell PB, Smythe GA.
    Psychiatry Res; 1991 Nov 13; 39(2):141-53. PubMed ID: 1686811
    [Abstract] [Full Text] [Related]

  • 53. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats.
    Laferrere B, Wurtman RJ.
    Brain Res; 1989 Dec 18; 504(2):258-63. PubMed ID: 2480833
    [Abstract] [Full Text] [Related]

  • 54. Effect of fenfluramine on prolactin and thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in obese and normal women.
    Argenio G, Bernini G, Vivaldi MS, Del Corso C, Monzani F, Baschieri L, Bertolozzi G, Santoni R, Franchi F, Luisi M.
    Eur J Clin Pharmacol; 1990 Dec 18; 39(1):13-6. PubMed ID: 2125937
    [Abstract] [Full Text] [Related]

  • 55. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
    Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL.
    Am J Psychiatry; 1997 Oct 18; 154(10):1430-5. PubMed ID: 9326827
    [Abstract] [Full Text] [Related]

  • 56. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
    Bernini GP, Argenio GF, Vivaldi MS, Del Corso C, Sgrò M, Franchi F, Luisi M.
    Horm Res; 1989 Oct 18; 31(3):133-7. PubMed ID: 2501208
    [Abstract] [Full Text] [Related]

  • 57. Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.
    Walsh AE, Ware CJ, Cowen PJ.
    Psychopharmacology (Berl); 1991 Oct 18; 105(4):568-72. PubMed ID: 1663254
    [Abstract] [Full Text] [Related]

  • 58. Effect of lithium on prolactin responses to thyrotropin releasing hormone in patients with manic state.
    Tanimoto K, Maeda K, Yamaguchi N, Chihara K, Fujita T.
    Psychopharmacology (Berl); 1981 Oct 18; 72(2):129-33. PubMed ID: 6782601
    [Abstract] [Full Text] [Related]

  • 59. The influence of cortisol on spontaneous and 5HT stimulated prolactin release in man.
    Dinan TG, Scott LV.
    J Basic Clin Physiol Pharmacol; 1996 Oct 18; 7(1):45-56. PubMed ID: 8983335
    [Abstract] [Full Text] [Related]

  • 60. Effect of chronic lithium treatment on 5-hydroxytryptamine autoreceptors and release of 5-[3H]hydroxytryptamine from rat brain cortical, hippocampal, and hypothalamic slices.
    Friedman E, Wang HY.
    J Neurochem; 1988 Jan 18; 50(1):195-201. PubMed ID: 2826685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.